Literature DB >> 6691428

Parkinsonian side effects induced by a monoamine oxidase inhibitor.

J P Teusink, G S Alexopoulos, C A Shamoian.   

Abstract

A 75-year-old depressed woman treated with the monoamine oxidase inhibitor (MAOI) phenelzine developed a parkinsonian syndrome that remitted after discontinuation of the drug. The authors discuss possible explanations for this unusual phenomenon.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6691428     DOI: 10.1176/ajp.141.1.118

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  3 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

3.  Parkinsonism induced by a monoamine oxidase inhibitor.

Authors:  M A Gillman; R Sandyk
Journal:  Postgrad Med J       Date:  1986-03       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.